Intravenous iron isomaltoside 1000 (Monofer
®
) reduces postoperative anaemia in preoperatively non‐anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double‐blind placebo‐controlled clinical trial (the
PROTECT
trial)
2016 ◽
Vol 8
(1)
◽
pp. 1-7
◽
2016 ◽
Vol 34
(4)
◽
pp. 276-282
◽
2015 ◽
Vol 183
◽
pp. 149-155
◽
2021 ◽
Vol 10
(2)
◽
pp. 675